However, recent intense efforts in identifying or designing inhibitors that interfere with the interaction between HIV-IN and the LEDGF/p75 IBD [161,162,163,164] promises to yield novel LEDGF/p75-targeting compounds that could potentially be repurposed for cancer treatment. Here, PSIP1 is linked to cancer.